Reduced neutron production through use of a flattening-filter-free accelerator

被引:62
作者
Kry, Stephen F.
Titt, Uwe
Poenisch, Falk
Vassiliev, Oleg N.
Salehpour, Mohammad
Gillin, Michael
Mohan, Radhe
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Phys, Unit 94, Houston, TX 77030 USA
[2] Tech Univ Dresden, Fak Med, D-8027 Dresden, Germany
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 68卷 / 04期
关键词
neutron; flattening filter; dose equivalent; activation; risk; intensity-modulated radiotherapy; IMRT;
D O I
10.1016/j.ijrobp.2007.04.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To measure and compare neutron fluence around an accelerator operating at 18 MV, both with the flattening filter present (FF mode) and absent (flattening-filter-free [FFF] mode). Methods and Materials: The neutron fluence was measured at several locations in the patient plane using gold foil activation in-neutron moderators. Differences in neutron fluence between the FF and FFF mode were assessed in three frameworks: (1) measured per monitor unit of machine-on time, (2) determined per dose on the central axis, and (3) determined for a complete course of prostate intensity-modulated radiotherapy. Results: Neutron fluence per monitor unit was approximately 20% lower when the accelerator was operated in the FFF mode than when it was in FF mode. The total amount of neutron fluence that would be obtained during the entire course of prostate intensity-modulate radiotherapy was 69% lower when the accelerator was operated in the FFF mode than when it was in the FF mode. This reduction in neutron fluence would correspond to a drastic reduction in the neutron dose equivalent received by the patient as a byproduct of high-energy radiotherapy. It would also correspond to a reduction in activation within the treatment vault and subsequent exposure to radiation therapists. Conclusion: When feasible, operating the accelerator without a FF will benefit both patients and radiation therapists by reducing the number of unwanted neutrons and resultant exposure. This reduces the risk of negative effects from such exposure (e.g., second cancers). (C) 2007 Elsevier Inc.
引用
收藏
页码:1260 / 1264
页数:5
相关论文
共 19 条
[1]   PHOTONEUTRONS FROM MEDICAL LINEAR ACCELERATORS - RADIOBIOLOGICAL MEASUREMENTS AND RISK ESTIMATES [J].
HALL, EJ ;
MARTIN, SG ;
AMOLS, H ;
HEI, TK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (01) :225-230
[2]   Investigation of MLC effects on secondary neutron spectra for Varian, Siemens, and Elekta [J].
Howell, R. ;
Kry, S. ;
Followill, D. ;
Hertel, N. ;
Wang, Z. ;
Salehpour, M. .
MEDICAL PHYSICS, 2006, 33 (06) :2249-2250
[3]   Measurements of secondary neutron dose from 15 MV and 18 MV IMRT [J].
Howell, RM ;
Ferenci, MS ;
Hertel, NE ;
Fullerton, GD ;
Fox, T ;
Davis, LW .
RADIATION PROTECTION DOSIMETRY, 2005, 115 (1-4) :508-512
[4]   Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies [J].
Howell, RM ;
Hertel, NE ;
Wang, ZL ;
Hutchinson, J ;
Fullerton, GD .
MEDICAL PHYSICS, 2006, 33 (02) :360-368
[5]   Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy [J].
Kry, SF ;
Salehpour, M ;
Followill, DS ;
Stovall, M ;
Kuban, DA ;
White, RA ;
Rosen, II .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (04) :1204-1216
[6]   The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy [J].
Kry, SF ;
Salehpour, M ;
Followill, DS ;
Stovall, M ;
Kuban, DA ;
White, RA ;
Rosen, II .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (04) :1195-1203
[7]   Neutron sources in the Varian Clinac 2100C/2300C medical accelerator calculated by the EGS4 code [J].
Mao, XS ;
Kase, KR ;
Liu, JC ;
Nelson, WR ;
Kleck, JH ;
Johnsen, S .
HEALTH PHYSICS, 1997, 72 (04) :524-529
[8]   DOSE TO RADIOTHERAPY TECHNOLOGIST FROM AIR ACTIVATION [J].
MCGINLEY, PH ;
WRIGHT, BA ;
MEDING, CJ .
MEDICAL PHYSICS, 1984, 11 (06) :855-858
[9]  
*NAT COUNC RAD PRO, 1990, 104 NCRP
[10]  
NATH R, 1986, 19 AAPM